BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 25865950)

  • 1. Erdheim-Chester disease.
    Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
    Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erdheim-Chester disease.
    Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
    Rheum Dis Clin North Am; 2013 May; 39(2):299-311. PubMed ID: 23597965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
    Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erdheim-Chester disease.
    Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
    Curr Rheumatol Rep; 2014 Apr; 16(4):412. PubMed ID: 24532298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
    Haroche J; Papo M; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Presse Med; 2017 Jan; 46(1):96-106. PubMed ID: 27234902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.
    Guo S; Yan Q; Rohr J; Wang Y; Fan L; Wang Z
    Hum Pathol; 2015 Jan; 46(1):159-64. PubMed ID: 25454479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erdheim-Chester disease].
    Mazor RD; Shoenfeld Y
    Harefuah; 2014 Jul; 153(7):389-91, 434, 433. PubMed ID: 25189027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erdheim-Chester Disease: a comprehensive review of the literature.
    Mazor RD; Manevich-Mazor M; Shoenfeld Y
    Orphanet J Rare Dis; 2013 Sep; 8():137. PubMed ID: 24011030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cytologic diagnosis of BRAF
    Chasseur P; Kyriakopoulou M; Vokaer B; Beukinga I; Casado Arroyo R; Cogan E; Couturier B
    Acta Clin Belg; 2017 Oct; 72(5):369-371. PubMed ID: 28222655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoalphalipoproteinemia and BRAF
    Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.
    Haroche J; Cohen-Aubart F; Emile JF; Maksud P; Drier A; Tolédano D; Barete S; Charlotte F; Cluzel P; Donadieu J; Benameur N; Grenier PA; Besnard S; Ory JP; Lifermann F; Idbaih A; Granel B; Graffin B; Hervier B; Arnaud L; Amoura Z
    J Clin Oncol; 2015 Feb; 33(5):411-8. PubMed ID: 25422482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults.
    Cao XX; Sun J; Li J; Zhong DR; Niu N; Duan MH; Liang ZY; Zhou DB
    Ann Hematol; 2016 Apr; 95(5):745-50. PubMed ID: 26858028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Understanding and Management of Erdheim-Chester Disease.
    Kulkarni AM; Gayam PKR; Aranjani JM
    Life Sci; 2024 Jul; 348():122692. PubMed ID: 38710283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
    Haroche J; Cohen-Aubart F; Emile JF; Arnaud L; Maksud P; Charlotte F; Cluzel P; Drier A; Hervier B; Benameur N; Besnard S; Donadieu J; Amoura Z
    Blood; 2013 Feb; 121(9):1495-500. PubMed ID: 23258922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erdheim-Chester disease: a systematic review.
    Cives M; Simone V; Rizzo FM; Dicuonzo F; Cristallo Lacalamita M; Ingravallo G; Silvestris F; Dammacco F
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):1-11. PubMed ID: 25744785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erdheim Chester disease with appendicular skeletal, renal and pleural involvement responding to Zelboraf (BRAF inhibitor) treatment: case report.
    Borys D; Nystrom L; Song A; Lomasney LM
    Skeletal Radiol; 2016 Oct; 45(10):1397-402. PubMed ID: 27423231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvement.
    Bunaux K; Sevestre H; Emile JF; Capel C; Chenin L; Peltier J
    Neurochirurgie; 2018 Dec; 64(6):439-441. PubMed ID: 30274919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erdheim-Chester disease-A histiocytic multisystem disease with unusual renal involvement].
    Dasdelen S; Büschek F
    Internist (Berl); 2020 Sep; 61(9):969-979. PubMed ID: 32785740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Neuroimaging Manifestations of Erdheim-Chester Disease: A Review.
    Garg N; Lavi ES
    J Neuroimaging; 2021 Jan; 31(1):35-44. PubMed ID: 32920940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series.
    Mazor RD; Manevich-Mazor M; Kesler A; Aizenstein O; Eshed I; Jaffe R; Pessach Y; Goldberg I; Sprecher E; Yaish I; Gural A; Ganzel C; Shoenfeld Y
    BMC Med; 2014 Dec; 12():221. PubMed ID: 25434739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.